Codexis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Codexis and other ETFs, options, and stocks.About CDXS
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments.
CEOAlison Moore
CEOAlison Moore
Employees188
Employees188
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2002
Founded2002
Employees188
Employees188
CDXS Key Statistics
Market cap147.23M
Market cap147.23M
Price-Earnings ratio-2.14
Price-Earnings ratio-2.14
Dividend yield—
Dividend yield—
Average volume1.20M
Average volume1.20M
High today$1.66
High today$1.66
Low today$1.58
Low today$1.58
Open price$1.64
Open price$1.64
Volume982.34K
Volume982.34K
52 Week high$5.51
52 Week high$5.51
52 Week low$1.52
52 Week low$1.52
Stock Snapshot
Codexis(CDXS) stock is priced at $1.61, giving the company a market capitalization of 147.23M. It carries a P/E multiple of -2.14.
On 2026-01-04, Codexis(CDXS) stock moved within a range of $1.58 to $1.66. With shares now at $1.61, the stock is trading +1.9% above its intraday low and -3.0% below the session's peak.
Trading activity shows a volume of 982.34K, compared to an average daily volume of 1.2M.
Over the past 52 weeks, Codexis(CDXS) stock has traded between a high of $5.51 and a low of $1.52.
Over the past 52 weeks, Codexis(CDXS) stock has traded between a high of $5.51 and a low of $1.52.
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
28.6%
Sell
0%
People also own
Based on the portfolios of people who own CDXS. This list is generated using Robinhood data, and it’s not a recommendation.